Lumenis Launches Four New Modes of the AcuPulse™ CO2 Laser at the European Academy of Dermatology and Venereology (EADV)

Ten modes now treat patients from head to toe.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
AcuPulse with SuperPulse technology now offers physicians a total of ten different modes, allowing for unmatched versatility for treating 34 aesthetic indications.

Yokneam, Israel (PRWEB) September 27, 2012

Lumenis Ltd., the world's largest medical laser company which develops, manufactures and distributes a broad range of medical lasers and sophisticated energy delivery equipment for surgical, aesthetic and ophthalmic applications, announces the launch of its upgraded AcuPulse™ CO2 Laser, with four new modes of treatment. AcuPulse with SuperPulse technology now offers physicians a total of ten different modes, allowing for unmatched versatility for treating 34 aesthetic indications.

Lumenis will showcase the versatile and affordable AcuPulse laser at the 21st European Academy of Dermatology and Venereology (EADV) to be held in Prague, Czech Republic on September 27-30, 2012.

The four new treatment modes which have been added to the AcuPulse include:

  •     Combo™ - Combo mode maximizes time and efficiency by safely treating both superficial and deep targets in a single scan. This can be used for facial lines, wrinkles or sun damage, and in the same scan, deep irregular lesions.
  •     StretchTouch™ - StretchTouch treats skin furrows and other textual irregularities on larger body areas using SuperPulse technology.
  •     FineTouch™ - FineTouch can be used for precise ablation and coagulation of irregular pigmented lesions at various depths.
  •     ToeTouch™ - ToeTouch offers a solution to podiatry ailments using continuous wave ablation. Now physicians can treat toenail fungus, plantar warts, ingrown toenails and more.

“Lumenis recognizes the importance of being able to offer physicians a rich range of treatment options while economizing on capital costs,” says Rami Sharon, President of Lumenis EMEA. “Built on Lumenis’ 40 year experience with CO2 technology, AcuPulse continues the tradition of providing gold standard CO2 devices to physicians.”

“I have found that FineTouch mode on AcuPulse has the precision that I need to treat fine pigmented lesions. I have also found that FineTouch has the capability to ablate layers evenly into deep nevus cells with visual contact,” says Dr. Nariaki Miyata, Director of Miyata Plastic Surgery and Dermatology Clinic in Japan. “The FineTouch mode is very easy to control and easy to operate with minimum damage to normal tissue that is unrivalled by any other products.”

Treatments performed with the AcuPulse can be done using the SurgiTouch™ or AcuScan120™ high precision scanners. The AcuScan120 incorporates precision optics with real-time monitoring algorithms for treating fractionally both superficially and deep. The SurgiTouch scanner enjoys a reputation of quality and precision based on extensive clinical experience.

Conference Details:

Lumenis will be presenting at Booth #99 in Prague Congress Centre, 5. Kvetna 65.
Attendees are welcome to join the following “meet the expert” sessions:

Dr. Gerd Kautz - Meet the expert session 05
September 28, 2012 12.00 – 13.00, room Club E, 1st floor
Topic: M22 – IPL and Nd:YAG Platform: Overview, experiences, updates

Dr. Matteo Tretti Clementoni - Meet the expert session 08
September 28, 2012 17.30 – 18.30, room E, 1st floor
Topic: Significant Improvement in Wrinkles and Pigmentation with Combination Mode CO2 Therapy

Dr. Klaus Hoffmann - Meet the expert session 11
September 29, 2012 17.30 – 18.30, room E, 1st floor
Topic: LightSheer Duet - Diode Laser - Gold Standard for Hair Removal

For more information, contact Lumenis or visit http://www.lumenis.com.

About Lumenis

Lumenis, the world's largest medical laser company, is a global developer, manufacturer and distributor of laser and light-based devices for surgical, aesthetic and ophthalmic applications, with more than 900 employees worldwide. Lumenis has 265 registered patents, over 260 FDA clearances, an installed base of over 80,000 systems and a presence in over 80 countries. Lumenis endeavors to bring the finest state of the art technology products to the market, fulfilling the highest standards of excellence, quality and reliability, delivering premium value and service to its customers. The name Lumenis is derived from the Latin words meaning ”Light of Life” highlighting the light - the basis of our technologies - used to enhance life. For more information about Lumenis and its products, please visit: http://www.lumenis.com.

For further information contact:
Julie Shafiki
Director, Global Marketing Communications
+972-4-959-9113
e-mail: julie.shafiki (at) lumenis (dot) com

Lumenis® and the Lumenis logo are trademarks or registered trademarks of Lumenis.
AcuPulse™, Combo™, StretchTouch™, FineTouch™ and ToeTouch™ are trademarks of Lumenis.


Contact

  • Julie Shafiki
    Lumenis LTD
    +972-544991970
    Email